JOMPAC
Journal of Medicine and Palliative Care

Journal of Medicine and Palliative Care (JOMPAC) is an open access scientific journal with independent, unbiased, and double-blind review under international guidelines. The purpose of JOMPAC is to contribute to the literature by publishing articles on health sciences and medicine.

eISSN: 2717-7505
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Submit Manuscript

Index
Original Article
Examining the relationship between the atherogenic index of plasma and coronary plaque burden: insights from a retrospective intravascular ultrasound analysis
Abstract
Aims: In the context of coronary artery disease development, inflammation and lipid metabolism play significant roles. This study explores the link between the Atherogenic Index of Plasma (AIP) and plaque burden in intravascular ultrasound (IVUS) examined patients.
Methods: A retrospective analysis included seventy-six consecutive IVUS patients from June 2020 to May 2023. AIP, calculated as the log of plasma triglyceride divided by high-density lipoprotein cholesterol, measured atherogenicity. Plaque burden, a percentage, was determined by dividing the total plaque area by the total vessel area. Multivariate regression and Spearman’s correlation analyzed the relationship between AIP and high plaque burden.
Results: The median age was 59 years, with 72.4% males. Univariate analysis identified age, diabetes mellitus (DM), smoking, and AIP as plaque burden predictors. Multivariate analysis showed AIP (OR=1.53, 95% CI:1.12-2.02, p=0.021) and DM independently predicted high plaque burden (OR=1.03, 95% CI:1.01-1.45, p=0.044). Spearman’s correlation indicated a positive correlation between AIP and high plaque burden (rho: 0.682, p<0.05).
Conclusion: This study suggests AIP, a surrogate marker of atherosclerosis, may predict plaque burden in IVUS-examined patients.

Keywords : Atherogenic index of plasma, coronary plaque burden, intravascular ultrasound

Download Article


1. Ford T J, Corcoran D, Berry C. Stable coronary syndromes:pathophysiology, diagnostic advances and therapeutic need.Heart. 2018;104:284-292.
2. Weber C, Noels H. Atherosclerosis: current pathogenesis andtherapeutic options. Nat Med. 20017;17(11):1410-1422.
3. Knuuti J, Wijns W, Saraste A. et al. 2019 ESC Guidelines for thediagnosis and management of chronic coronary syndromes:the Task Force for the diagnosis and management of chroniccoronary syndromes of the European Society of Cardiology(ESC). Europ Heart J. 2019;41(3):407-477.
4. Raygor V, Khera A. New recommendations and revised conceptsin recent guidelines on the management of dyslipidemias toprevent cardiovascular disease: The 2018 ACC/AHA and 2019ESC/EAS guidelines. Curr Cardiol Reports. 2019;22(9):87.
5. Erdoğan A, İnan D, Gen&ccedil; &Ouml;, et al. The triglyceride-glucose indexmight be a better indicator for predicting poor cardiovascularoutcomes in chronic coronary syndrome. J Clin Med. 2023;12(19):6201.
6. Zhu XW, Deng FY, Lei SF. Meta-analysis of the atherogenic indexof plasma and other lipid parameters in relation to risk of type 2diabetes mellitus. Prim Care Diabetes. 2015;9(1):60-67.
7. Cai G, Shi G, Xue S, Lu W. The atherogenic index of plasma is astrong and independent predictor for coronary artery disease inthe Chinese Han population. Medicine. 2017;96(37):e8058.
8. Yueqiao S, Wenjun F, Chao H, Jingyi L, Lixian S. Atherogenicindex of plasma, triglyceride- glucose index and monocyte-to-lymphocyte ratio for predicting subclinical coronary arterydisease. Am J Med Sci. 2021;362(3):285-290.
9. Won KB, Heo R, Park HB, et al. Atherogenic index of plasma andthe risk of rapid progression of coronary atherosclerosis beyondtraditional risk factors. Atherosclerosis. 2021;324:46-51.
10. Mao Q, Zhou D, Li Y, Wang Y, Xu SC, Zhao XH. Thetriglyceride-glucose index predicts coronary artery diseaseseverity and cardiovascular outcomes in patients with non-ST-segment elevation acute coronary syndrome. Dis Markers.2019;2019:6891537.
11. Nam JS, Kim MK, Nam JY, et al. Association between theatherogenic index of plasma and coronary artery calcificationprogression in Korean adults. Lipids Health Dis. 2020;19(1):1-7.
12. Weber C, Noels H. Atherosclerosis: current pathogenesis andtherapeutic options. Nat Med. 20017;17(11):1410-1422.
13. Cheng JM, Suoniemi M, Kardys I, et al. Plasma concentrationsof molecular lipid species in relation to coronary plaquecharacteristics and cardiovascular outcome: results of theATHEROREMO-IVUS study. Atherosclerosis. 2015;243(2):560-566.
14. Yan PF, Liu L, Yuan J, Xu CX, Song D, Yan H. The racialdifferences in the clinical outcomes of intravascular ultrasound-guided percutaneous coronary intervention: a systematic reviewand meta-analysis. Am J Cardiol. 2023;203:193-202.
15. Saito Y, Kobayashi Y, Fujii K, et al. CVIT 2023 clinical expertconsensus document on intravascular ultrasound. CardiovascInter Ther. 2023;39(1):1-14.
16. R&auml;ber L, Mintz GS, Koskinas KC, et al. Clinical use ofintracoronary imaging. Part 1: guidance and optimization ofcoronary interventions. An expert consensus document ofthe European Association of Percutaneous CardiovascularInterventions. Eur Heart J. 2018;39(35):3281-3300.
17. Hunsicker LG, Adler S, Caggiula A, et al. Predictors of theprogression of renal disease in the Modification of Diet in RenalDisease Study. Kidney Int. 1997;51(6):1908-1919.
18. Chobanian AV, Bakris GL, Black HR, et al. Seventh reportof the joint national committee on prevention, detection,evaluation, and treatment of high blood pressure. Hypertension.2003;42(6):1206-1252.
19. Expert Panel on Detection, Evaluation, and Treatment of HighBlood Cholesterol in Adults. Executive summary of the thirdreport of the National Cholesterol Education Program (NCEP)expert panel on the detection, evaluation, and treatment of highblood cholesterol in adults (Adult Treatment Panel III). JAMA.2001;285(19):2486-2497.
20. He Y , Li Z, Yu L, et al. Association between the atherogenic indexof plasma and carotid artery plaques in patients with coronaryheart disease in different glucose metabolism states: an RCSCD-TCM study in Tianjin, China. Endocrine. 2023;81(2):252-261.
21. Dobi&aacute;sov&aacute; M, Frohlich J. The plasma parameter log (TG/HDL-C)as an atherogenic index: correlation with lipoprotein particlesize and esterification rate in apoB-lipoprotein-depleted plasma(FER(HDL)). Clin Biochem. 2001;34(7):583-588.
22. Dobi&aacute;sov&aacute; M, Frohlich J, Sedov&aacute; M, Cheung MC, Brown BG.Cholesterol esterification and atherogenic index of plasmacorrelate with lipoprotein size and findings on coronaryangiography. J Lipid Res. 2011;52:566-571.
23. Shen S, Lu Y, Qi H, et al. Association between ideal cardiovascularhealth and the atherogenic index of plasma. Medicine.2016;95(24):e3866.
24. Niroumand S, Khajedaluee M, Khadem-Rezaiyan M, et al.Atherogenic Index of Plasma (AIP): a marker of cardiovasculardisease. Med J Islam Repub Iran. 2015;29:240.
25. Ono M, Kawashima H, Hara H, et al. Advances in IVUS/OCTand future clinical perspective of a novel hybrid catheter systemin coronary imaging. Front Cardiovasc Med. 2020;31:7-119.
Article available in :
Volume 5, Issue 1, 2024
Page : 23-28
https://doi.org/10.47582/jompac.1421199
Article Information
Submitted : 17 Oca 2024
Accepted : 05 Şub 2024
Corresponding Author :

Aslan Erdoğan: Department of Cardiology, Başakşehir Çam and Sakura City Hospital, İstanbul, Turkiye

[email protected]
Citation : Erdoğan A, Özkan E. Examining the relationship between the atherogenic index of plasma and coronary plaque burden: insights from a retrospective intravascular ultrasound analysis. J Med Palliat Care. 2024;5(1):23-28.

Read: 23
Cited: 0
Download : 14
_Footer